UPDATED Apr 25, 2024
Companies with a Value score of at least 3, ordered by Value score
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VOD | UK£9,283.50 | 4.8% | 69.2% | UK£18.7b | UK£12,619.31 | PE2.1x | E-40.8% | 11.2% | Telecom | ||
CSCOD | US$10.00 | -0.5% | 5.3% | US$194.8b | US$11.09 | PE14.5x | E0.6% | 3.3% | Tech | ||
NVSD | CHF24.25 | 5.0% | n/a | CHF181.8b | CHF26.94 | PE21.8x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
GSKD | UK£10.30 | 1.0% | 11.1% | UK£67.0b | UK£12.63 | PE13.6x | E9.3% | 3.5% | Pharmaceuticals & Biotech | ||
WBAD | US$6.20 | 1.6% | -50.0% | US$15.4b | US$8.22 | PB1.1x | E68.4% | 5.7% | Consumer Retailing | ||
BNGD | US$23.85 | 9.2% | 27.5% | US$15.0b | US$26.86 | PE7.9x | E-14.2% | 2.5% | Food, Beverage & Tobacco | ||
ORAN | €12,051.00 | 1.5% | 101.3% | €27.9b | €15,153.35 | PE12.3x | E10.1% | 6.9% | Telecom | ||
PHG | €4,462.00 | 5.1% | 143.0% | €17.5b | €4,715.34 | PB1.5x | E66.3% | n/a | Healthcare | ||
NVS | CHF26,891.50 | 9.0% | 131.8% | CHF183.6b | CHF29,502.85 | PE22.1x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
NTCOY | R$6,298.00 | 0% | 214.9% | R$22.8b | R$8,089.46 | PB1x | E94.9% | 1.3% | Household | ||
SBS | R$33,805.00 | 2.2% | 287.6% | R$56.4b | R$39,034.74 | PE16x | E15.1% | 1.7% | Utilities | ||
SPCE | US$1,886.00 | -18.0% | n/a | US$353.9m | US$5,822.51 | PS52x | E42.6% | n/a | Capital Goods | ||
NTESD | US$7.75 | 0% | n/a | US$60.7b | US$10.94 | PE14.9x | E7.9% | 2.7% | Media | ||
MOD | US$11.15 | 4.2% | -9.0% | US$73.6b | US$12.12 | PE9.1x | E2.2% | 9.1% | Food, Beverage & Tobacco | ||
CSCO | US$10,390.00 | 1.5% | 141.5% | US$195.8b | US$11,520.44 | PE14.5x | E0.6% | 3.3% | Tech | ||
CBDBY | R$459.00 | -6.9% | -65.3% | R$1.4b | R$725.79 | PB0.3x | E-1.5% | 0% | Consumer Retailing | ||
YY | US$7,040.00 | 1.5% | 154.5% | US$2.0b | US$9,403.18 | PE5.8x | E-12.0% | 2.4% | Media | ||
TD | US$5.86 | 2.6% | -7.0% | US$118.9b | US$7.08 | PE8.9x | E5.2% | 6.7% | Telecom | ||
GSK | UK£11,000.00 | 5.4% | 167.1% | UK£67.0b | UK£13,449.37 | PE13.6x | E9.3% | 3.5% | Pharmaceuticals & Biotech | ||
HWM | US$68,273.50 | 1.3% | 243.8% | US$26.4b | US$75,493.45 | PE34.7x | E14.8% | 0.3% | Capital Goods | ||
ZMD | US$1.33 | 6.4% | -9.5% | US$19.0b | US$1.71 | PE29.5x | E4.2% | n/a | Software | ||
TV | Mex$1,057.50 | 5.3% | 41.9% | Mex$27.5b | Mex$1,684.93 | PB0.2x | E70.6% | 3.5% | Media | ||
UAL | US$11,500.00 | 4.3% | 194.5% | US$17.6b | US$14,175.89 | PE6.5x | E9.1% | n/a | Transportation | ||
BAD | US$7.01 | -4.9% | -20.2% | US$102.4b | US$9.63 | PS1.3x | E54.2% | 0% | Capital Goods |